Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Strange who wrote (200)	7/8/1997 9:01:00 PM
From: John Zwiener	of 10280

Albuterol is one of the best drugs available for asthma, but the side effects are definitely a limiting factor. More therapy with fewer side effects makes the prospect of dominating or replacing albuterol very likely. I don't know why it would levalbutol would cost other than albutorol going off patent. Cost is important when there is an equivelent cheaper drug, but levalbuterol appears to be clearly better, very important in such a useful drug. A likely blockbuster drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next